Literature DB >> 5476141

An acceptable slow-release phosphate preparation "slow P".

V Parsons, A Porter, C Lund.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5476141      PMCID: PMC2467064          DOI: 10.1136/pgmj.46.537.417

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  17 in total

1.  THE TUBULAR MAXIMAL RESORPTIVE RATE FOR INORGANIC PHOSPHATE IN NORMAL SUBJECTS.

Authors:  J ANDERSON; V PARSONS
Journal:  Clin Sci       Date:  1963-12       Impact factor: 6.124

2.  TREATMENT OF THE ADULT FANCONI SYNDROME WITH ORAL PHOSPHATE SUPPLEMENTS AND ALKALI. REPORT OF TWO CASES ASSOCIATED WITH NEPHROLITHIASIS.

Authors:  D R WILSON; E R YENDT
Journal:  Am J Med       Date:  1963-10       Impact factor: 4.965

3.  STUDIES IN PARATHYROID PHYSIOLOGY: III. The Effect of Phosphate Ingestion in Clinical Hyperparathyroidism.

Authors:  F Albright; W Bauer; D Claflin; J R Cockrill
Journal:  J Clin Invest       Date:  1932-03       Impact factor: 14.808

4.  Effect of phosphate supplements in patients with fractures.

Authors:  R S Goldsmith; C F Woodhouse; S H Ingbar; D Segal
Journal:  Lancet       Date:  1967-04-01       Impact factor: 79.321

5.  Total urinary hydroxyproline in osteomalacia and the effect upon it of treatment with vitamin D.

Authors:  R Smith; M Dick
Journal:  Clin Sci       Date:  1968-02       Impact factor: 6.124

6.  Inorganic phosphate treatment of hypercalcemia.

Authors:  S G Massry; E Mueller; A G Silverman; C R Kleeman
Journal:  Arch Intern Med       Date:  1968-04

7.  Total urinary hydroxyproline excretion in osteomalacia.

Authors:  J Anderson; D W Bannister; V Parsons; R W Tomlinson
Journal:  Calcif Tissue Res       Date:  1967-12-20

8.  Potassium chloride and intestinal ulceration.

Authors:  V Wynn
Journal:  Lancet       Date:  1965-12-11       Impact factor: 79.321

9.  The treatment of adult phosphate diabetes and Fanconi syndrome with neutral sodium phosphate.

Authors:  C Nagant de Deuxchaisnes; S M Krane
Journal:  Am J Med       Date:  1967-10       Impact factor: 4.965

10.  Phosphate treatment of hypercalcaemia due to carcinoma.

Authors:  N Thalassinos; G F Joplin
Journal:  Br Med J       Date:  1968-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.